Biblio

Export 1713 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2024
M. Sultana, Camicioli, R., Dixon, R. A., Whitehead, S., Pieruccini-Faria, F., Petrotchenko, E., Speechley, M., Borchers, C. H., and Montero-Odasso, M., “A Metabolomics Analysis of a Novel Phenotype of Older Adults at Higher Risk of Dementia.”, J Alzheimers Dis, vol. 99, no. s2, pp. S317-S325, 2024.
Y. Li, Chen, X., Zhou, M., Feng, S., Peng, X., and Wang, Y., “Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 75-88, 2024.
Y. Cabrera-León, Báez, P. García, Fernández-López, P., and Suárez-Araujo, C. Paz, “Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.”, J Alzheimers Dis, vol. 98, no. 3, pp. 793-823, 2024.
Z. Shen, Yang, X., Lan, Y., and Chen, G., “The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 741-754, 2024.
R. A. Mace, Lyons, C., Cohen, J. E., Ritchie, C., Bartels, S., Okereke, O. I., Hoeppner, B. B., Brewer, J. A., and Vranceanu, A. - M., “Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.”, J Alzheimers Dis, vol. 100, no. 4, pp. 1237-1259, 2024.
J. M. Chandler, Ye, W., Mi, X., Doty, E. G., and Johnston, J. A., “Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
C. Cressot, Vrillon, A., Lilamand, M., Francisque, H., Méauzoone, A., Hourregue, C., Dumurgier, J., Marlinge, E., Paquet, C., and Cognat, E., “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
C. Cressot, Vrillon, A., Lilamand, M., Francisque, H., Méauzoone, A., Hourregue, C., Dumurgier, J., Marlinge, E., Paquet, C., and Cognat, E., “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
Y. Okinaka, Shinagawa, Y., Claussen, C., Gul, S., Matsui, I., Matsui, Y., and Taguchi, A., “RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1673-1683, 2024.
G. Alva, Cubała, W. J., Berrio, A., Coate, B., Abler, V., and Pathak, S., “Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.”, J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.
G. Alva, Cubała, W. J., Berrio, A., Coate, B., Abler, V., and Pathak, S., “Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.”, J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.
S. Duchesne, Rousseau, L. - S., Belzile-Marsolais, F., Welch, L. - A., Cournoyer, B., Arseneau, M., Lapierre, V., Poulin, S. - M., Potvin, O., and Hudon, C., “A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.”, J Alzheimers Dis, vol. 99, no. 3, pp. 843-856, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
M. Carpi, Fernandes, M., Mercuri, N. Biagio, and Liguori, C., “Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.”, J Alzheimers Dis, vol. 97, no. 1, pp. 121-143, 2024.
Y. Huang, Driedonks, T. A. P., Cheng, L., Turchinovich, A., Pletniková, O., Redding-Ochoa, J., Troncoso, J. C., Hill, A. F., Mahairaki, V., Zheng, L., and Witwer, K. W., “Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S235-S248, 2024.
A. Payen, Bateman, J. R., Muralidhara, S. Dhanavanth, Sachs, B. C., Cleveland, M., Yang, M., Lockhart, S. N., Craft, S., and Bennett, J. M., “Social support may buffer the effect of ε4 allele on cognition in older adults.”, J Alzheimers Dis, vol. 102, no. 4, pp. 967-974, 2024.
A. Payen, Bateman, J. R., Muralidhara, S. Dhanavanth, Sachs, B. C., Cleveland, M., Yang, M., Lockhart, S. N., Craft, S., and Bennett, J. M., “Social support may buffer the effect of ε4 allele on cognition in older adults.”, J Alzheimers Dis, vol. 102, no. 4, pp. 967-974, 2024.
S. Martínez-López, Tabone, M., Clemente-Velasco, S., González-Soltero, M. Del Rocío, Bailén, M., de Lucas, B., Bressa, C., Domínguez-Balmaseda, D., Marín-Muñoz, J., Antúnez, C., Gálvez, B. G., and Larrosa, M., “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
J. Rodrigo Do Santos, Catalão, C. Henrique R., Vulczak, A., Azzolini, A. Elisa Cale, and Alberici, L. Carla, “Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.”, J Alzheimers Dis, vol. 102, no. 2, pp. 424-436, 2024.
2025
H. Tong, Petyuk, V. A., Sendtner, M., Sood, A., Bennett, D. A., Capuano, A. W., and Arvanitakis, Z., “Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
D. Hu, Chen, M., Li, X., Daley, S., Morin, P., Han, Y., Hemberg, M., Weiner, H. L., and Xia, W., “ApoE ε4-dependent Alteration of CXCR3  CD127 CD4 T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251320123, 2025.
E. Guzmán-Vélez, Aguillón, D., Rivera-Hernández, A., Baena, A. Y., Londoño-Sotomayor, N., Picard, G., Kramer, A. F., Arnold, S. E., Caraballo-Gracia, D. I., J Taylor, A., and Quiroz, Y. T., “Association among cardiorespiratory fitness, plasma biomarkers of pathology and astrocyte reactivity, and cognition in autosomal-dominant Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251344327, 2025.

Pages